Stockholm, Sweden · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing and Reimbursement, Health Technology Assessment (HTA), Oncology, Stakeholder Management
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Contracting, Launch Readiness, Market Access, Pharmaceutical Law, Team Leadership
Stockholm, Sweden · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing And Reimbursement, Health Technology Assessment, Stakeholder Management, Value Dossier Development
Stockholm, Sweden · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, Oncology Product Launch, People Management, Market Access, Demand Generation
Amsterdam, North Holland, Netherlands · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Affairs Strategy, Oncology, KOL Management, Product Launch, HTA Hearings
Redwood City, California, United States · On-site
$170k–$212k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Synthetic Organic Chemistry, Process Research And Development, CDMO Management, Quality By Design, Design Of Experiment
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Safety Surveillance, Signal Detection, Risk Management, Medical Review
Redwood City, California, United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory Strategy, Companion Diagnostics, In Vitro Diagnostics, Oncology Drug Development, FDA Regulations
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Data Management, EDC Systems, UAT, CDISC, SDTM
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Data Management, Oncology, EDC Systems, Medidata Rave, CDISC Standards
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: CRM Management, Omnichannel Enablement, Business Analysis, Stakeholder Management, Veeva CRM
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Data Management, Vendor Management, EDC Database Development, Case Report Forms, Medical Coding
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: ASC 606 Revenue Recognition, Gross-to-Net (GTN) Accounting, GTN Forecasting, SOX Compliance, US GAAP
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Congress Strategy, Event Execution, Project Management, Cross-functional Leadership, Vendor Management
Redwood City, California, United States · Hybrid
$213k–$244k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Patent Preparation, Patent Prosecution, Freedom-To-Operate Analysis, Landscape Monitoring, Small Molecule IP
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Statistical Programming, Oncology Clinical Trials, CDISC Standards, SDTM, ADaM
Vienna, Austria · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: KOL Relationship Management, Scientific Communication, Oncology Expertise, Clinical Research Methodologies, Drug Development
Amsterdam, North Holland, Netherlands · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, Oncology Product Launch, People Management, Market Access, Demand Generation
Amsterdam, North Holland, Netherlands · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing And Reimbursement, Health Technology Assessment, Stakeholder Management, Oncology
Redwood City, California, United States · On-site
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Process Research And Development, Scale-up Manufacturing, Quality By Design, Design Of Experiment, Technology Transfer
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Define and execute the market access and reimbursement strategy for oncology therapies across the Nordics to ensure sustainable patient access. Lead engagement with payers, HTA bodies, and health authorities while developing evidence-based value dossiers and pricing models.
Requires a minimum of 10 years of experience in market access, pricing, or health economics within the Nordics pharmaceutical or biotech sector. An advanced degree in Life Sciences, Pharmacy, or Health Economics is preferred, along with a proven track record in oncology product launches.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Reporting to the Country Manager Nordics, the Medical Director, Nordics is the medical leader responsible for defining and executing the local medical strategy RevMed portfolio and launches. This role serves as the medical voice within the Nordics Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that Nordics medical considerations are embedded in the regional medical strategy and plans and will partner with the Country Manager and crossfunctional teams, as well as the Sr Dir Medical Affairs Midsized Markets and VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Nordics medical team and work closely with the Midsized Markets crossfuncitonal and cross-country teams, Global and Regional Medical Affairs teams across Med Affairs functions.
Act as the Medical Affairs lead for Nordics, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with country regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Collaborate effectively with Midsized Markets, Regional and Global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the country Medical Affairs team when/if applicable, including Medical advisors and MSLs.
Establish medical processes, governance, and ways of working as part of the country build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and regional codes, and internal company policies.
Represent Medical Affairs in country governance and risk management forums.
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of Nordics payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in Nordics.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a biotech and/or in a build-out.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Willingness to travel nationally and internationally.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-Hybrid #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineRevolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution Medicine